These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 27340673)

  • 61. Variation in allergen content in sublingual allergen immunotherapy with house dust mites.
    Moreno Benítez F; Espinazo Romeu M; Letrán Camacho A; Mas S; García-Cózar FJ; Tabar AI
    Allergy; 2015 Nov; 70(11):1413-20. PubMed ID: 26185961
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Letter to the Editor: Can dog allergen immunotherapy reduce concomitant allergic sensitization to other furry animals? A preliminary experience.
    Liccardi G; Calzetta L; Salzillo A; Billeri L; Lucà G; Rogliani P
    Eur Ann Allergy Clin Immunol; 2017 Mar; 49(2):92-96. PubMed ID: 28294591
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Ultra short pre-seasonal subcutaneous immunotherapy and pre-coseasonal sublingual immunotherapy for pollen allergy: an evaluation of patient's preference in real life.
    Manzotti G; Pappacoda A; Dimatteo M; Scolari C; Riario-Sforza GG; Incorvaia C
    Eur Ann Allergy Clin Immunol; 2013 Aug; 45(4):138-43. PubMed ID: 24067339
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Clinical benefits of treatment with SQ house dust mite sublingual tablet in house dust mite allergic rhinitis.
    Demoly P; Kleine-Tebbe J; Rehm D
    Allergy; 2017 Oct; 72(10):1576-1578. PubMed ID: 28273339
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Short-course sublingual immunotherapy by mucoadhesive patch and tolerogenic particle enhanced allergen presentation.
    Sørensen P; Turánek-Knotigová P; Mašek J; Kotouček J; Hubatka F; Mašková E; Kulich P; Lubasová D; Raška M; Leenhouts K; Turánek J
    Clin Exp Allergy; 2021 Jun; 51(6):853-857. PubMed ID: 33682209
    [No Abstract]   [Full Text] [Related]  

  • 66. Long-Term Efficacy of Sublingual Mite Immunotherapy in Monosensitized and Polysensitized Children with Allergic Rhinitis: A 7-Year Prospective Study.
    Cui L; Li J; Li Y; Xia Z
    Int Arch Allergy Immunol; 2019; 180(2):144-149. PubMed ID: 31256165
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Oral and Sublingual Immunotherapy for Treatment of IgE-Mediated Food Allergy.
    Scurlock AM
    Clin Rev Allergy Immunol; 2018 Oct; 55(2):139-152. PubMed ID: 29656306
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Sublingual immunotherapy in the United States: history and current relevance in the time of COVID-19.
    Lin SY
    Int Forum Allergy Rhinol; 2020 Oct; 10(10):1125-1126. PubMed ID: 32783396
    [No Abstract]   [Full Text] [Related]  

  • 69. Sublingual immunotherapy of allergic diseases.
    Werner-Klein M; Kalkbrenner F; Erb KJ
    Expert Opin Drug Deliv; 2006 Sep; 3(5):599-612. PubMed ID: 16948556
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Sublingual Immunotherapy for Allergic Fungal Sinusitis.
    Melzer JM; Driskill BR; Clenney TL; Gessler EM
    Ann Otol Rhinol Laryngol; 2015 Oct; 124(10):782-7. PubMed ID: 25902841
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Therapeutic procedures of sublingual immunotherapy in clinical practice.
    Zwacka G; Markert UR
    Chem Immunol Allergy; 2003; 82():44-52. PubMed ID: 12947991
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Perception and practice of sublingual immunotherapy among practicing allergists in the United States: a follow-up survey.
    Sikora JM; Tankersley MS;
    Ann Allergy Asthma Immunol; 2013 Mar; 110(3):194-197.e4. PubMed ID: 23548531
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Efficacy but not effectiveness of sublingual immunotherapy for grass pollen allergy: Time to avoid waste in health-care expenditure.
    Corrao S; Di Bona D; Di Lorenzo G
    Eur J Intern Med; 2015 Oct; 26(8):561-2. PubMed ID: 26377975
    [No Abstract]   [Full Text] [Related]  

  • 74. Allergen Immunotherapy.
    Rael E
    Prim Care; 2016 Sep; 43(3):487-94. PubMed ID: 27545737
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Safety of sublingual immunotherapy in children.
    Frati F; Ridolo E; Fuiano N; Barberi S; Dell'Albani I; Landi M; Ricciardi L; Scala G; Incorvaia C
    Expert Opin Drug Saf; 2014 Jul; 13(7):947-53. PubMed ID: 24821477
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Emerging concepts of sublingual immunotherapy for allergy.
    Theodoropoulos DS; Morris MS; Morris DL
    Drugs Today (Barc); 2009 Oct; 45(10):737-50. PubMed ID: 20069138
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Treatment of respiratory allergy with allergy immunotherapy tablets.
    Bachert C
    Allergy; 2011 Jul; 66 Suppl 95():57-9. PubMed ID: 21668858
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Recent development on the use of sublingual immunotherapy tablets for allergic rhinitis.
    Waserman S; Shah A; Avilla E
    Ann Allergy Asthma Immunol; 2021 Aug; 127(2):165-175.e1. PubMed ID: 34029713
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The history of sublingual immunotherapy.
    Pajno GB; Barberi S
    Int J Immunopathol Pharmacol; 2009; 22(4 Suppl):1-3. PubMed ID: 19944001
    [TBL] [Abstract][Full Text] [Related]  

  • 80. How does sublingual immunotherapy work?
    Frew AJ
    J Allergy Clin Immunol; 2007 Sep; 120(3):533-6. PubMed ID: 17765753
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.